Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-03

Clinical Trial Update: Neuroprotection With Minocycline Therapy for Acute Stroke Recovery Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating minocycline for neuroprotection in acute stroke has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Singhealth Foundation | Conditions: Acute Stroke | Phase 4 | Status: TERMINATED